Position in JNJ
as of Jun 30, 2026
· filed Jul 2, 2026
Position Value
$96,762
+$2,164 QoQ
Shares Held
381
-1.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.65%
of 13F equity value
Holder Rank
#4,576
of 4,676 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sarver Vrooman Wealth Advisors holds $412,483 across 5 Drug Manufacturers - General names. JNJ ranks #2 (23.5% of the industry book) .
All Filings in JNJ
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $96,762 | 381 | Shares | Sole | 2026-07-02 | |
| 2026-03-31 | $94,598 | 387 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $89,609 | 433 | Shares | Sole | 2026-04-23 | |
| 2025-09-30 | $107,914 | 582 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $88,900 | 582 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $113,102 | 682 | Shares | Sole | 2025-07-08 | |
| No filing history on record for this holder in this stock. | ||||||